I am rather curious/concerned about this one. As if we model nerve regneration treatments in humans on the processes scripted by worm genetics, then patients treated so I expect will be more sensitive to deworming compounds found in dietary sources. (e.g. avermectins in pork and salmon - toxic to worms and lice by interference with neural action of gamma amino butyric acid.) Also there are exisiting human therapeutic uses of avermectins.
This is a tricky road to go down, to model modifications of our own biology to that of lower species, particularly parasites. Such drugs or therapies have a much larger chance of negative interactions with existing therapeutic regimes.
A good analogy might be software dependencies. You know what? It really is a question of software dependencies when you think about it. Far out.